Jill M. Jene, Ph.D. has been appointed vice president, business development, PDL BioPharma, Inc. Dr. Jene will lead the efforts to add healthcare assets to PDL’s portfolio of products and companies. She will report to PDL President, Dominique Monnet.   “Jill brings to PDL more than 20 years of biopharmaceutical business development experience and an exceptional track-record of success spanning more than $3 billion in licensing and M&A transactions,” said Mr. Monnet. &#822...